BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10430645)

  • 1. Osteogenesis imperfecta: bone turnover, bone density, and ultrasound parameters.
    Cepollaro C; Gonnelli S; Pondrelli C; Montagnani A; Martini S; Bruni D; Gennari C
    Calcif Tissue Int; 1999 Aug; 65(2):129-32. PubMed ID: 10430645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M; Fukunaga M; Ohtawa T; Harada T
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced serum levels of carboxy-terminal propeptide of human type I procollagen in a family with type I-A osteogenesis imperfecta.
    Minisola S; Piccioni AL; Rosso R; Romagnoli E; Pacitti MT; Scarnecchia L; Mazzuoli G
    Metabolism; 1994 Oct; 43(10):1261-5. PubMed ID: 7934978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis.
    Antoniazzi F; Bertoldo F; Mottes M; Valli M; Sirpresi S; Zamboni G; Valentini R; Tató L
    J Pediatr; 1996 Sep; 129(3):432-9. PubMed ID: 8804334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone turnover in hyperthyroidism before and after thyrostatic management.
    Isaia GC; Roggia C; Gola D; Stefano MD; Gallone G; Aimo G; Ardissone P; Mussetta M
    J Endocrinol Invest; 2000 Dec; 23(11):727-31. PubMed ID: 11194705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
    Scillitani A; Chiodini I; Carnevale V; Giannatempo GM; Frusciante V; Villella M; Pileri M; Guglielmi G; Di Giorgio A; Modoni S; Fusilli S; Di Cerbo A; Liuzzi A
    J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta.
    Kocijan R; Muschitz C; Haschka J; Hans D; Nia A; Geroldinger A; Ardelt M; Wakolbinger R; Resch H
    Osteoporos Int; 2015 Oct; 26(10):2431-40. PubMed ID: 25956285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome.
    Cortet B; Cortet C; Blanckaert F; d'Herbomez M; Marchandise X; Wémeau J-L ; Decoulx M; Dewailly D
    Osteoporos Int; 2001; 12(2):117-23. PubMed ID: 11303711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone metabolism in endurance trained athletes: a comparison to population-based controls based on DXA, SXA, quantitative ultrasound, and biochemical markers.
    Brahm H; Ström H; Piehl-Aulin K; Mallmin H; Ljunghall S
    Calcif Tissue Int; 1997 Dec; 61(6):448-54. PubMed ID: 9383270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
    Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commencing, continuing and stopping brisk walking: effects on bone mineral density, quantitative ultrasound of bone and markers of bone metabolism in postmenopausal women.
    Brooke-Wavell K; Jones PR; Hardman AE; Tsuritan ; Yamada Y
    Osteoporos Int; 2001; 12(7):581-7. PubMed ID: 11527057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.
    Kotzmann H; Riedl M; Bernecker P; Clodi M; Kainberger F; Kaider A; Woloszczuk W; Luger A
    Calcif Tissue Int; 1998 Jan; 62(1):40-6. PubMed ID: 9405732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone formation markers in adults with mild osteogenesis imperfecta.
    Cundy T; Horne A; Bolland M; Gamble G; Davidson J
    Clin Chem; 2007 Jun; 53(6):1109-14. PubMed ID: 17434905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
    Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
    Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.
    Ueda M; Inaba M; Okuno S; Nagasue K; Kitatani K; Ishimura E; Shimizu M; Miki T; Kim M; Nishizawa Y
    Am J Kidney Dis; 2002 Oct; 40(4):802-9. PubMed ID: 12324916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.